📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Exacis

1.1 - Company Overview

Exacis Logo

Exacis

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of development-stage immuno-oncology solutions, using mRNA-based cell reprogramming to create iPSC and mRNA-based gene editing to engineer iPSC, creating engineered NK and T cells designed to resist host immune rejection to harness the human immune system against cancer.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Exacis

Sellas Life Sciences Logo

Sellas Life Sciences

HQ: Bermuda Website
  • Description: Provider of late-stage cancer immunotherapies, developing Galinpepimut-S (GPS), a WT1-targeting synthetic heteroclitic epitope immunotherapeutic for various cancers to prevent relapses and potentially improve survival, and SLS009, a highly selective small molecule CDK9 inhibitor for development and commercialization worldwide outside the Greater China Region.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sellas Life Sciences company profile →
Bright Peak Therapeutics Logo

Bright Peak Therapeutics

HQ: Switzerland Website
  • Description: Provider of immunotherapies for cancer and autoimmune diseases, enabling tissue- and cell-specific cytokine targeting with enhanced efficacy. Offerings include Bright Peak Immunoconjugates combining optimized cytokines with antibodies; a chemical protein synthesis platform for novel proteins; and candidates such as BPT567 (PD1-IL18), BPT331 (PD1-IL2), and BPT331CAPS (PD1-IL2CAPS).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bright Peak Therapeutics company profile →
Selexis Logo

Selexis

HQ: Switzerland Website
  • Description: Provider of proprietary technology and highly specialized expertise for mammalian (suspension-adapted CHO-K1) cell line generation, helping translate scientific innovation into life-saving medicines for patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Selexis company profile →
Scancell Logo

Scancell

HQ: United Kingdom Website
  • Description: Provider of immunotherapy platforms and therapeutic vaccines for cancer and infectious diseases, including ImmunoBody and Moditope for cancer vaccines, GlyMab for glycan-targeting monoclonal antibodies, AvidiMab to enhance antibody potency and tumor specificity, and melanoma vaccines SCIB1 and iSCIB1+.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Scancell company profile →
CellPoint Logo

CellPoint

HQ: The Netherlands Website
  • Description: Provider of point-of-care CAR-T therapy solutions enabling clinicians to retarget patient immune cells to treat hematological malignancies, with a 6-day manufacturing process powered by the proprietary xCellit real-time monitoring software system that allows for 1 week vein-to-vein time, making therapies more affordable and accessible.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CellPoint company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Exacis

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Exacis

2.2 - Growth funds investing in similar companies to Exacis

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Exacis

4.2 - Public trading comparable groups for Exacis

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Exacis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Exacis

What does Exacis do?

Exacis is a provider of development-stage immuno-oncology solutions, using mRNA-based cell reprogramming to create iPSC and mRNA-based gene editing to engineer iPSC, creating engineered NK and T cells designed to resist host immune rejection to harness the human immune system against cancer.

Who are Exacis's competitors?

Exacis's competitors and similar companies include Sellas Life Sciences, Bright Peak Therapeutics, Selexis, Scancell, and CellPoint.

Where is Exacis headquartered?

Exacis is headquartered in United States.

How many employees does Exacis have?

Exacis has 1,000 employees 🔒.

When was Exacis founded?

Exacis was founded in 2010 🔒.

What sector and industry vertical is Exacis in?

Exacis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Exacis

Who are the top strategic acquirers in Exacis's sector and industry

Top strategic M&A buyers and acquirers in Exacis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Exacis?

Top strategic M&A buyers groups and sectors for Exacis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Exacis's sector and industry vertical

Which are the top PE firms investing in Exacis's sector and industry vertical?

Top PE firms investing in Exacis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Exacis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Exacis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Exacis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Exacis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Exacis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Exacis?

The key public trading comparables and valuation benchmarks for Exacis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Exacis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Exacis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Exacis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Exacis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Exacis's' sector and industry vertical?

Access recent funding rounds and capital raises in Exacis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Exacis